Related Experiment Videos

The canine p53 gene is subject to somatic mutations in thypoid carcinoma

P Devilee1, I S Van Leeuwen, A Voesten

  • 1Department of Pathology, University of Leiden, The Netherlands.

Anticancer Research
|September 1, 1994
PubMed

Insights

Researchers cloned a conserved segment of the canine p53 tumor suppressor gene to study canine cancer evolution. This gene shows similar function and mutation patterns to human p53, suggesting its role in canine malignancy.

Area of Science:

  • Molecular Biology
  • Oncology
  • Comparative Genomics

Background:

  • The p53 tumor suppressor gene is frequently altered in human and mouse cancers.
  • Understanding canine p53 is crucial for developing molecular tools to study canine tumor evolution.

Purpose of the Study:

  • To clone and characterize a conserved segment of the canine p53 homologue.
  • To investigate the potential role of p53 in canine malignancy.

Main Methods:

  • Cloning of a 534 bp genomic segment of canine p53 (exons 5-7 and intervening introns).
  • Sequence analysis to assess homology with other species.
  • mRNA expression analysis in normal tissues and cell lines.
  • Mutation screening in canine thyroid carcinomas.

Main Results:

  • The cloned canine p53 segment shows strong homology to human, mouse, and Xenopus laevis.
  • Conserved gene organization at both DNA and amino acid levels was observed.
  • Canine p53 mRNA is expressed in normal tissues and kidney cell lines.
  • A specific mutation (A-->G T transversion) was identified in one thyroid carcinoma, predicting an amino acid substitution.

Conclusions:

  • The cloned canine p53 segment provides a molecular tool for studying canine tumor genetics.
  • p53 appears to play a role in canine cancer development, similar to its role in humans.

Related Concept Videos